Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.82 USD | +1.41% | -0.49% | -15.55% |
Evolution of the average Target Price on Rhythm Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Rhythm Pharmaceuticals, Inc.
Wells Fargo Securities | |
Goldman Sachs | |
Needham & Co. | |
Morgan Stanley | |
BofA Securities | |
Canaccord Genuity | |
Stifel Nicolaus | |
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- RYTM Stock
- Consensus Rhythm Pharmaceuticals, Inc.